MENLEY & JAMES INC
10-Q, 1996-08-13
PHARMACEUTICAL PREPARATIONS
Previous: SUBURBFED FINANCIAL CORP, 10QSB, 1996-08-13
Next: AMYLIN PHARMACEUTICALS INC, 10-Q, 1996-08-13



<PAGE> 1

                   UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                                Washington, D.C. 20549

                                       FORM 10-Q

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                            SECURITIES EXCHANGE ACT OF 1934
                    For the quarterly period ended June 30, 1996
                                                              
                         Commission File Number: 000-19788
                                                              


                               MENLEY & JAMES, INC.
              (Exact name of registrant as specified in its charter)


                     Delaware                    23-2621602
               (State of incorporation)         (I.R.S. Employer
                                                 Identification No.)


                              100 Tournament Drive
                           Horsham, Pennsylvania  19044
                     (Address of principal executive office)

                                (215) 441-6500
                          Registrant's telephone number 
                                                              


  Indicate by  check mark whether the registrant (1) has filed all reports
required to be  filed by Section 13 or 15(d) of the Securities Exchange Act of
1934  during the  preceding 12  months (or  for such  shorter period  that the
registrant  was required to  file such reports),  and (2) has  been subject to
such filing requirements for the past 90 days.
Yes [X]   No [ ]     

  The number of  shares of the  registrant's common stock, par  value $.01
per share, outstanding as of August 9, 1996, was 6,148,518.

<PAGE> 2

                          MENLEY & JAMES, INC.
                                INDEX
                                                                      Page No.
                     PART I - FINANCIAL INFORMATION

Item 1.  Financial Statements (unaudited).

Condensed Consolidated Balance Sheets - June 30, 1995, 
  December 31, 1995 and June 30, 1996  . . . . . . .. . . . . . . . .        3

Condensed Consolidated Statements of Operations - 
  Three Months and Six Months Ended June 30, 1995 and 1996   .  . . .        4

Condensed Consolidated Statements of Cash Flows - Six Months
  Ended June 30, 1995 and 1996   . . . . . . . . . . . . . . . . . . .       5

Notes to Condensed Consolidated Financial Statements  . . . . . . . .        6

Item 2.  Management's Discussion and Analysis of 
           Financial Condition and Results of Operations  . . . . . .        7



                        PART II - OTHER INFORMATION   

Item 1.  Legal Proceedings  . . . . . . . . . . . . . . . . . . . .          8

Item 2.  Changes in Securities  . . . . . . . . . . . . . . . . . .          8

Item 3.  Defaults Upon Senior Securities  . . . . . . . . . . . . .          8

Item 4.  Submission of Matters to a Vote of Security Holders  . . .          8

Item 5.  Other Information  . . . . . . . . . . . . . . . . . . . .          8

Item 6.  Exhibits and Reports on Form 8-K . . . . . . . . . . . . .          8

Signature . . . . . . . . . . . . . . . . . . . . . . . . . . . . .          9

<PAGE> 3

                                MENLEY & JAMES, INC.
                       Condensed Consolidated Balance Sheets
                                   (In thousands)

                                         June 30,    December 31,    June 30,
                                           1995          1995          1996    
                                       -----------   -----------    ---------  
                                       (Unaudited)                 (Unaudited)

          ASSETS

Current assets:
  Cash and cash equivalents   . . . . .  $   662       $   988       $   1,464 
  Accounts receivable, net of allowances 
    of $633 and $653 in 1995 and $642
    in 1996  . . . . . . . . . . . . . .   3,042         3,133           2,393 
  Inventory   . . . . . . . . . . . . .    4,348         3,825           3,879 
  Other current assets  . . . . . . . .    1,500         1,296           1,097 
                                         -------       -------         -------
  Total current assets  . . . . . . . .    9,552         9,242           8,833 
Other long-term assets  . . . . . . . .    1,430         1,525           1,438 
Product lines, trade names and
  packaging designs, net . . . . . . . .  13,931        13,281          12,781 
Long-term deferred tax asset  . . . . .      967           707             565 
                                         -------       -------         -------
  Total assets  . . . . . . . . . . . .  $25,880       $24,755         $23,617 
                                         =======       =======         =======

      LIABILITIES AND STOCKHOLDERS' EQUITY 

Current liabilities:
 Accounts payable  . . . . . . . . . . . $   995       $   815         $   677 
 Accrued expenses  . . . . . . . . . . .     779           573             323 
 Current maturities of long-term debt  .   1,200         1,157           1,214 
                                           -----         -----           -----
 Total current liabilities . . . . . . .   2,974         2,545           2,214 
Long-term debt   . . . . . . . . . . . .   1,800         1,005             404 
Preferred stock, $1 par value,
 authorized 5,000,000 shares,
 none issued and outstanding . . . . . .      --            --              -- 
Stockholders' equity:
 Common stock, $.01 par value,
  authorized 15,000,000 shares,
  issued and outstanding 6,148,518
  shares in 1995 and 1996 . . . . . . . .     61            61              61 
 Additional paid-in capital . . . . . . . 45,454        45,454          45,454 
 Accumulated deficit . . . . . . . . . . (24,409)      (24,310)        (24,516)
                                         -------       -------         -------
Total stockholders' equity. . . . . . . . 21,106        21,205          20,999
                                          ------        ------          ------
 Total liabilities and 
  stockholders' equity . . . . . . . . . $25,880       $24,755         $23,617 
                                          ======        ======          ======



                                         See accompanying notes.


<PAGE> 4

                                  MENLEY & JAMES, INC.
                    Condensed Consolidated Statements of Operations
                         (In thousands, except per share data)
                                       (Unaudited)


                                    Three Months Ended      Six Months Ended
                                         June 30,                 June 30,    
                                    1995           1996     1995        1996
                                    -------------------     ----------------

Net sales . . . . . . . . . . .  $ 3,620        $ 3,180    $ 7,020   $ 6,720 
Cost of goods sold  . . . . . .    1,782          1,633      3,411     3,491 
                                   -----          -----      -----     -----
Gross profit  . . . . . . . . .    1,838          1,547      3,609     3,229 
Selling, general and 
 administrative expenses. . . .    1,331          1,099      2,561     2,231 
Depreciation and amortization .      414            373        848       745 
                                   -----          -----      -----     -----
Income from operations  . . . .       93             75        200       253 
Interest expense  . . . . . . .       61             19        135        47
                                   -----          -----      -----     -----
Income before income taxes  . .       32             56         65       206 
Provision for income taxes  . .       22            299         45       412
                                   -----          -----      -----      ----- 
Net income (loss)   . . . . . .  $    10        $  (243)   $    20   $  (206)
                                   =====          =====      =====      =====
Net income (loss) per share 
  of common stock . . . . . . .  $  0.00        $ (0.04)   $  0.00   $ (0.03)
                                   =====          =====      =====     =====

Weighted average number of 
 common shares outstanding         6,148          6,148      6,148     6,148 
                                   =====          =====      =====     =====


                             See accompanying notes.


<PAGE>  5
                                 MENLEY & JAMES, INC.
                     Condensed Consolidated Statements of Cash Flows
                                    (In thousands)
                                     (Unaudited)

                                                     Six Months Ended
                                                         June 30,     
                                                     1995        1996
                                                   ------------------

Cash flows from operating activities:
 Net income (loss)    . . . . . . . . . .         $    20      $  (206)
 Adjustments to reconcile net 
  income (loss) to net cash provided 
  by operating activities:
  Depreciation and amortization   . . . .             848          745 
  Amortization of deferred 
   financing costs  . . . . . . . . . . .              19           18 
  Deferred income taxes   . . . . . . . .              45          412 
Changes in operating assets and liabilities:
  Accounts receivable   . . . . . . . . .             664          740 
  Inventory   . . . . . . . . . . . . . .             254          (54)
  Prepaid expenses  . . . . . . . . . . .             (49)         (81)
  Accounts payable  . . . . . . . . . . .             (81)        (138)
  Accrued expenses  . . . . . . . . . . .            (232)        (250)
                                                    -----        -----
Net cash provided by 
 operating activities  . . . . . . . . .            1,488        1,186 

Cash flows used in investing activities:
 Other, principally property
   purchases, net   . . . . . . . . . . .            (77)         (166)

Cash flows used in financing activities:
 Repayment of borrowings  . . . . . . . .         (1,300)         (544)
                                                   -----         -----
 Net increase in cash  . . . . . . . . . .           111           476 
Cash and cash equivalents, 
  beginning of period  . . . . . . . . . .           551           988 
                                                   -----         -----
Cash and cash equivalents, 
  end of period  . . . . . . . . . . . . .       $   662       $ 1,464 
                                                 =======       =======

                                        See accompanying notes.


<PAGE> 6
                                  MENLEY & JAMES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The  accompanying unaudited condensed  consolidated financial  statements have
been prepared in accordance with  generally accepted accounting principles for
interim financial information and with the  instructions to Form 10-Q and Rule
10-01  of  Regulation S-X.  Accordingly, they do not  include  all of  the
information and footnotes required by generally accepted accounting principles
for  complete financial  statements.    In  the  opinion  of  management,  all
adjustments (consisting of normal recurring accruals) considered necessary for
a fair presentation have been included.  For further information, refer to the
consolidated  financial  statements  and  footnotes thereto  included  in  the
Company's annual report  on Form 10-K  for the year  ended December 31,  1995.
Operating  results  for the  six-month  period ended  June  30,  1996 are  not
necessarily indicative of the results that may be expected for the year ending
December 31, 1996.

NOTE A - INVENTORIES

Inventories consist of the following (in thousands): 

                                  June 30,       December 31,       June 30,
                                    1995             1995             1996      



Raw materials . . . . . . . .       $ 950          $ 1,253          $ 1,172
Work in process . . . . . . .         382              307              236
Finished goods  . . . . . . .       3,016            2,265            2,471
                                    -----            -----            -----
                                  $ 4,348          $ 3,825          $ 3,879
                                    =====            =====            =====

NOTE B - INCOME TAXES

The effective tax  rate exceeds the statutory federal tax  rate primarily as a
result  of the  amortization of  product lines  and trade  names which  is not
deductible for tax purposes.

<PAGE> 7

Item 2: Management's  Discussion and  Analysis  of Financial  Condition and
        Results of Operations

Results of Operations

Net  sales  for the  three months  ended June  30, 1996  were $3.2  million, a
decrease of $440 thousand, compared to $3.6 million for the three months ended
June 30,  1995.  Net sales  for the six months  ended June 30,  1996 were $6.7
million compared to $7.0 million for the comparable 1995 period.  The decrease
in net sales is a continuation in the decline in sales trends due to continued
competition and trade destocking pressure.

Cost of goods sold for the second quarter of 1996 was $1.6 million compared to
$1.8  million  in  1995,  representing  51% and  49%  of  net  sales  in their
respective periods.  Year-to-date cost of goods sold was $3.5  million, or 52%
of  net sales, compared to  $3.4 million, or  49% of net sales  for 1995.  The
increase  in the cost of goods sold, as  a percentage of sales, is primarily a
result of the mix-of-products sold.

Selling,  general and  administrative expenses  for the  three- and  six-month
periods  of  1996 were  $1.1  million and  $2.2  million, a  decrease  of $232
thousand  and  $330 thousand  compared to  the  respective 1995  periods. This
decrease is primarily related to cost reduction efforts.  Selling, general and
administrative  expenses, as a percentage  of sales, may  fluctuate quarter to
quarter based  upon the timing  of these expenditures  and the level  of sales
within a quarter.

Interest expense,  including finance cost  amortization, was $19  thousand for
the  second  quarter of  1996, compared  to $61  thousand  for the  prior year
period.  Year-to-date  interest expense was $47 thousand for  1996 compared to
$135  thousand  for the  prior  year period.   The  decrease  is due  to lower
outstanding  debt.  Bank  debt outstanding at  June 30, 1996  was $1.6 million
compared to $3.0 million outstanding at June 30, 1995.

The Company, at December 31,  1995, had a net operating loss  carryforward for
federal income tax purposes of approximately $7.7 million which may be used to
offset future taxable  income.   These net operating  loss carryforwards  will
expire  during  the years  2005  through 2008.    The Company  recognized $299
thousand  in tax  expense for the  second quarter  of 1996,  and $412 thousand
year-to-date.  The effective tax rate  exceeds the statutory federal tax  rate
primarily  as a result  of the amortization  of product lines  and trade names
which is not  deductible for tax purposes.   The Company has  net deferred tax
assets of $1.1 million in its  condensed consolidated balance sheet as of June
30,  1996,  which is  primarily  made  up of  two  items,  net operating  loss
carryforwards and future deductible expenses.

For  the quarter  ended June  30, 1996,  the Company  had a  net loss  of $243
thousand or $0.04 per share compared to a net  income of $10 thousand or $0.00
per share, for the quarter ended June 30, 1995.  For the six months ended June
30, 1996,  the Company had  a net loss of  $206 thousand, or  $0.03 per share,
compared  to net income  of $20 thousand,  or $0.00 per  share, during the six
months ended June 30, 1995.

<PAGE> 8

Liquidity and Capital Resources

At June  30, 1996, the Company had  working capital of $6.6  million.  Working
capital was  provided  by its  operations  and may  also  be provided  by  the
seasonal  use of its revolving credit facility.  The revolving credit facility
has a maximum borrowing limit of $3.0 million and terminates on June 30, 1998,
unless extended.  At June 30, 1996, the Company had no amount outstanding 
under the revolving credit facility. The amount of borrowing, if used, and
the subsequent repayments under the facility would be a result of the 
seasonality  of the  Company's  sales, marketing  plans  and profits.  Also,
extended payment date terms consistent with  standard industry practice, which
are offered to the Company's customers under marketing programs, create
seasonal changes in the Company's cash flow.   These extended payment programs
are directly related to the seasonal promotion of the Company's cough and cold
brands.

As  of  June 30,  1996 the  Company had  $1.6 million  of debt  outstanding, a
reduction of $1.4 million since June 30, 1995.

At  the present  time, the  Company's  primary cash  requirements are  for its
normal operating activities and debt principal and interest service, including
required  current principal repayments of  $1.2 million on  the Company's term
loan.  The  Company  also   conducts  an  ongoing   program  of  evaluating
opportunities to acquire additional products to enhance its product portfolio.
Such   acquisitions  may   take  a  variety   of  forms   including  licensing
arrangements, purchases of trademarks and related inventories, acquisitions of
business  units or sales and  marketing agreements.   Management believes that
cash flow  from operations and current  and future borrowing capacity  will be
sufficient  to fund the Company's  operating and capital  requirements for the
foreseeable future.

                                      PART II - OTHER INFORMATION

Item 1.     Legal Proceedings                                       None
Item 2.     Changes in Securities                                   None
Item 3.     Defaults Upon Senior Securities                         None
Item 4.     Submission of Matters to a Vote of Security Holders     None
Item 5.     Other Information                                       None
Item 6.     Exhibits and Reports on Form 8-K

            a.  Exhibits                                            None

            b.  Reports on Form 8-K
                The registrant was not required to file any current reports
                 on Form 8-K during the three months ended June 30, 1996.


<PAGE> 9

                                  SIGNATURE



   Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                            MENLEY & JAMES, INC.



Date:  August 13, 1996                       William W. Yeager
                                                                              
                                             William W. Yeager
                                              Chief Financial Officer 
                                               (and duly authorized
                                                officer of the registrant) 




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission